WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002007710) DELIVERY DEVICE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/007710    International Application No.:    PCT/GB2001/003247
Publication Date: 31.01.2002 International Filing Date: 19.07.2001
Chapter 2 Demand Filed:    31.01.2002    
IPC:
A61K 9/48 (2006.01)
Applicants: MW ENCAP LIMITED [GB/GB]; 4 Dunlop Square Livingston West Lothian EH54 8SB (GB) (For All Designated States Except US).
BAKHSHAEE, Massoud [IR/GB]; (GB) (For US Only).
BOWTLE, William, John [GB/GB]; (GB) (For US Only).
MCNAUGHTON, Alyn, Brandon [GB/GB]; (GB) (For US Only)
Inventors: BAKHSHAEE, Massoud; (GB).
BOWTLE, William, John; (GB).
MCNAUGHTON, Alyn, Brandon; (GB)
Agent: BRITTER, Keith, Palmer; Britter and Co. Enterprise House 14b Whitehorse Street Baldock Hertfordshire SG7 5QN (GB)
Priority Data:
0017673.5 20.07.2000 GB
0028335.8 21.11.2000 GB
Title (EN) DELIVERY DEVICE
(FR) DISPOSITIF DE DELIVRANCE
Abstract: front page image
(EN)An active principle delivery device (1) comprising an inner capsule (4) within an outer capsule (2), the inner and outer capsules (4, 2) containing the same active principle (5, 3), with at least the outer capsule (2) being a hard capsule and the active principle (3, 5) in at least one of the capsules (2, 4), comprising a fluid. Also provided is a method of fabricating such a delivery device (1), as well as a method of controlling the pharmaco-kinetic profile of an active principle.
(FR)La présente invention concerne un dispositif (1) de délivrance de principe actif qui comprend une gélule interne (4) à l'intérieur d'une gélule externe (2), les gélules interne et externe (4, 2) contenant le même principe actif (5, 3), la gélule externe (2) au moins étant une gélule dure et le principe actif (3, 5) dans au moins l'une des gélules (2, 4) comprenant un fluide. L'invention se rapporte également à un procédé de fabrication du dispositif de délivrance de l'invention (1), ainsi qu'à un procédé permettant de réguler le profil pharmaco-cinétique d'un principe actif.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)